PRAMODINI MEDICARE LIMITED
ListedHealthcare · SME IPO · INE2JG601017
Price band
₹110 – ₹118
Lot size
1200 shares
Min. investment
₹2,83,200
Issue size
₹69 Cr
Face value
₹10
Registrar
Purva Sharegistry (India) Pvt.Ltd.
Issue timeline
Bidding opens
12 Aug 2026
Bidding closes
14 Aug 2026
Allotment
17 Aug 2026
Listing
19 Aug 2026
Final subscription
3.66x
overall
3,688
applications
₹194 Cr
bid value
| Category | Sub. (x) | Offered | Bid for | ₹ Cr* |
|---|---|---|---|---|
| Qualified Institutional (QIB) | 3.66x | 11,71,200 | 42,82,800 | 51 |
| Non-Institutional >₹10L (bNII) | 3.64x | 9,75,600 | 35,52,000 | 42 |
| Non-Institutional ₹2–10L (sNII) | 4.82x | 3,20,400 | 15,43,200 | 18 |
| Retail (RII) | 3.49x | 20,23,200 | 70,51,200 | 83 |
| Total | 3.66x | 44,90,400 | 1,64,29,200 | 194 |
Combined NSE + BSE subscription, sourced from the exchanges and updated periodically. * bid value approx (shares bid × cut-off price). Final subscription confirmed after the issue closes.
About the company
Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments.
Issue details
Issue size
₹69 Cr
Fresh issue
₹63 Cr
Offer for sale
₹6 Cr
Industry
Healthcare
Promoter holding (pre)
85.71%
Promoter holding (post)
62.64%
Financials (₹ Cr)
| Metric | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|
| Total income | 35.79 | 38.55 | 63.38 |
| EBITDA | 15.53 | 20.97 | 30.90 |
| Profit after tax | 7.14 | 11.14 | 17.38 Cr |
| Net worth | 24.75 | 35.77 | 53.15 Cr |
| Total assets | 48.78 | 56.45 | 93.62 |
| Total borrowing | 11.96 | 10.81 | 17.85 |
Objects of the issue
- Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres
- General corporate purposes and unidentified inorganic acquisition
Strengths
- Establishing a strategic presence across various states of India.
- Strengthening its network through diversified business models.
- Strong technical capabilities supported by robust IT infrastructure.
- Experienced management team with significant industry expertise.
- Consistent track record of revenue growth and financial performance.
- Diverse customer base, including hospitals, institutions, and individual patients.
Risks
- Dependence on government contracts and partnerships.
- Competition from other diagnostic service providers.
- Regulatory changes affecting healthcare services.
- Economic downturns impacting healthcare spending.
Documents
Calculate your bid
At cut-off price ₹118
Lots
2
- Shares
- 2,400
- Amount
- ₹2,83,200
Above ₹2,00,000 — this falls under the HNI / NII category, not Retail.
UPI mandate — funds are blocked, not debited.
- SEBI-registered broker — NSE member 90113
- Funds stay blocked in your own bank — debited only on allotment
- Apply for your whole family from one login